Xenetic Biosciences Inc. (XBIO)
NASDAQ: XBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
XBIO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.18M
- EPS (TTM)
- -$1.18
- Dividend yield
- None
- 52-week range
- 1.87 – 10.24
- Day range
- 2.11 – 2.21
- Volume / Avg
- 15.56K / 88.85K
- Beta
- —
- Shares outstanding
- 2.34M
52-week range
XBIO stock today
Xenetic Biosciences (XBIO) closed at $2.21 on Oct 7, up 2.55% (+$0.055), versus the S&P 500's 0.22% decline. Trading was light, with 15.56K shares changing hands, about 18% of the average daily volume. At this level, XBIO sits near the bottom of its 52-week range of $1.87 to $10.24: 78.4% below the high and 18.2% above the low.
Xenetic Biosciences has posted a net loss over the last twelve months (EPS of -$1.18), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Xenetic Biosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Xenetic Biosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LNAILunai Bioworks Inc. | 1.09 | -3.54% | $4.94M | vs XBIO |
| PULMPulmatrix Inc. | 1.49 | +4.20% | $5.44M | vs XBIO |
| PPCBPropanc Biopharma Inc. | 0.4987 | +1.51% | $4.90M | vs XBIO |
| ADXNAddex Therapeutics Ltd ADR | 3.13 | -0.32% | $5.49M | vs XBIO |
| XTLBXTL Biopharmaceuticals Ltd. ADR | 1.98 | -1.98% | $4.87M | vs XBIO |
| DRMADermata Therapeutics Inc. | 1.12 | -0.89% | $5.55M | vs XBIO |
| NCNANuCana plc ADR | 1.14 | +4.59% | $4.74M | vs XBIO |
| BGMSBio Green Med Solution Inc. | 0.85 | -0.67% | $5.63M | vs XBIO |
Indexes, lists and sector
Xenetic Biosciences stock FAQ
What is Xenetic Biosciences's stock price today?
XBIO last traded at $2.21 as of Oct 7, 4:00 PM EDT, up 2.55% on the day. Prices are delayed at least 15 minutes.
What is the XBIO 52-week high?
The 52-week high for XBIO is $10.24 and the 52-week low is $1.87. The stock is currently 78.4% below its high.